Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The longitudinal follow up the dynamics of tumor marker CYFRA21-1 establish a fact of local relapse in primary NSCLC (36 month follow up study on 500 patients) (CROSBI ID 484669)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Pavićević, Radomir ; Bubanović, Gordana ; Krajina, Ana ; Miličić, Jasna The longitudinal follow up the dynamics of tumor marker CYFRA21-1 establish a fact of local relapse in primary NSCLC (36 month follow up study on 500 patients) // The second European-American intensive course in clinical and forensic genetics.. Dubrovnik, 2001. str. 121-x

Podaci o odgovornosti

Pavićević, Radomir ; Bubanović, Gordana ; Krajina, Ana ; Miličić, Jasna

engleski

The longitudinal follow up the dynamics of tumor marker CYFRA21-1 establish a fact of local relapse in primary NSCLC (36 month follow up study on 500 patients)

The clinical application of cytokeratin marker CYFRA 21-1 was standardized on 3000 patients. In all patients the start value of CYFRA 21-1 was determined before therapy (electrochemiluminescence method, Roche Diagnostics). Tumor marker CYFRA 21-1 was assessed longitudinally 1-36 months after the therapy, or before the next therapy. One to three months after the surgical treatment in 97% of the patients the marker values decreased to the healthy population level, depending on the therapy and TNM stage (p<0.0001). The decrease appeared earlier in SQC then in AD and LCLC (Large Cell Lung Carcinoma) patients. Comparing clinical follow up data and CYFRA 21-1 marker as a prognostic factors for local relapse, it was found that tumor marker predicted the local relapse 1 to 12 months earlier in 235 out of 500 patients. Among those the majority had the start value above cut off level, which pointed to the earlier onset of local relapse and shorter survival period. The CYFRA 21-1 value depends on the tumor type, the location of local relapse and the measurement interval. The assessment of chemotherapy efficiency using CYFRA 21-1 marker will be shown in 141 patients. The elevated cytokeratin marker CYFRA 21-1 value is a biological signal of earlier events in lung tumor, which is why it becomes unavoidable diagnostic and prognostic marker within clinical procedure.

CYFRA-21-1 tumor marker; longitudinal follow up; lung cancer; NSCLC

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

121-x.

2001.

objavljeno

Podaci o matičnoj publikaciji

The second European-American intensive course in clinical and forensic genetics.

Dubrovnik:

Podaci o skupu

The Second European-American Intensive Course in Clinical and Forensic Genetics

poster

01.09.2001-14.09.2001

Dubrovnik, Hrvatska

Povezanost rada

Etnologija i antropologija